chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 2 minutes of receiving the injection, I experienced the following symptoms simultaneously: skin flushed/got hot, hands got numb and tingly, back of and sides of my tongue got thick- felt like it was swelling, got more difficult to breathe, heartbeat started racing, felt light-headed. I sat up in the edge of my seat and almost called for help, however the symptoms subsided within 2-3 minutes and then I was fine. Had a lingering, very minor headache and no other symptoms. I didn't tell anybody and came home and took 1 benadryl just to be safe.
neuropathy/ started acutely in feet bilaterally / persist intermittently in left extremities; One-time episode of upper extremity (UE) numbness; This is a spontaneous report from a contactable health care professional (patient). A 40-year-old female patient (not pregnant) received her 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot unknown) at single dose via an unknown route at left arm on 26Dec2020 for Covid-19 immunization. COVID-19 vaccine was administered in Pharmacy or Drug Store. Medical history was reported as "none". Patient had no COVID prior vaccination, further reported as patient was not diagnosed with COVID-19 prior to vaccination. No known medications, food, or other products allergies. Concomitant drugs (Other-medications-in-two weeks) included levocabastine hydrochloride (ZYRTEC), diphenhydramine hydrochloride (BENADRYL) as needed, ibuprofen (MOTRIN), and multivitamin. No other-vaccine-in-four weeks received.  Patient experienced adverse-event of neuropathy, which started acutely in feet bilaterally and now (as of 02Jan2021) persist intermittently in left extremities (LEs). One-time episode of upper extremity (UE) numbness. No weakness. Patient inquired if 2nd dose should be held. Adverse-event-start-date was 26Dec2020. The adverse event result in doctor or other healthcare professional office/clinic visit. No treatment received. The event was reported as non-serious. Since the vaccination, patient had not been tested for COVID-19. Outcome of the event was not resolved.    Information about lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of peripheral neuropathy and upper extremity (UE) numbness  due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics including head CT/MRI and nerve conduction tests, counteractive treatment measures and concomitant medications.  This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Site: Itching at Injection Site-Mild, Systemic: Allergic: Itch Generalized-Mild, Additional Details: Pt sat at observation for 30 min due to allergy history. Said she felt topical itching all over and at injection site. She was given benadryl 20 ml (50 mg) and monitored for relief. PT had husband drive her home and said her itching felt better after benadryl.
Pt noticed 1 to 2 days after getting HD flu vaccine - he had the sensation you feel after eating hot peppers - on his lips to tip of tongue. Lips feel as though better but not gone.
Information has been received from a physician concerning his 21 year old daughter, who in MAY-2007 was vaccinated with a first dose of Gardasil. Subsequently, the patient developed "dark discoloration" or "bruising" to her ankles and the bottom of her feet. The discoloration was most prominent during June and July 2007. On an unspecified date, the patient received her second dose of Gardasil. The patient was evaluated by her family physician. At the time of the report, the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Itching around eyes; swelling of eyelids; This is a spontaneous report from a non-contactable consumer (patient). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208 and expiration date: not reported), via an unspecified route of administration, in the left arm, on 16Mar2021 at 12:00 (at the age of 48-year-old) as dose 2, single dose for COVID-19 immunization. Medical history included allergy to sulfur containing antibiotics. Concomitant medications were not reported. Historical vaccine included BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number and expiration date: not reported ) via an unspecified route of administration, in the left arm, on 23Feb2021 at 17:00 (at the age of 48-year-old) as dose 1, single dose for COVID-19 immunization and experienced Itching around eyes. The patient was not pregnant at time of vaccination.  The patient had not received any other vaccines within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 17Mar2021, the patient experienced itching around eyes and swelling of eyelids. The event resulted in Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events itching around eyes and swelling of eyelids which included self-treatment with antihistamine on an unknown date in 2021 and Doctor rx'ed Benadryl and cortisone cream. The outcome of events itching around eyes and swelling of eyelids was recovering at time of report  No follow-up attempts are possible. No further information is expected.
colon polyps; This is a spontaneous report received from non-contactable reporter(s) (Other HCP).  An adult male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LARGE INTESTINE POLYP (non-serious), outcome "unknown", described as "colon polyps".  Additional information: Age/Date of Birth: 60-64 Years  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Severe dehydration; extreme fatigue; body aches; headache; fever-slight; This is a spontaneous report from a non-contactable consumer or other non hcp.   A 31-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 11May2021 16:30  (Age at vaccination 31 years old) (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was none known allergies: None. Concomitant medications included cyanocobalamin (B12-VITAMIN), zinc chloride (ZINC CHLORIDE) taken for an unspecified indication, start and stop date were not reported. Patient had covid prior vaccination. covid tested post vaccination was no.  other medications in two weeks was B12, elderberry, zinc, acid reflux medication.  On 12May2021 10:00 Severe dehydration, extreme fatigue, body aches, headache, fever-slight. Outcome of the event was not recovered.   No follow up attempts are possible. Information on Lot/batch number cannot be obtained.
Information has been received from a health professional concerning a female pt with a severe latex allergy who in 1995 was vaccinated SC with a 0.5 ml dose of MMR II. Subsequently the pt developed an allergic reaction. It was unknown if the pt recovered. Unspecified medical attention was sought. No further information is available.
Miscarriage; Patient was unaware that she was pregnant; This spontaneous case was reported by a nurse and describes the occurrence of ABORTION SPONTANEOUS (Miscarriage) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pregnancy test (Negative home pregnancy test.) on 02-Mar-2021.    On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Patient was unaware that she was pregnant). On 19-Mar-2021, the patient experienced ABORTION SPONTANEOUS (Miscarriage) (seriousness criterion medically significant). At the time of the report, ABORTION SPONTANEOUS (Miscarriage) and EXPOSURE DURING PREGNANCY (Patient was unaware that she was pregnant) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No treatment or concomitant mediation were reported.
Septic Arthritis:   This is an 81 yo female who initially presented to the hospital 11/9/22 not feeling well with generalized weakness.  Over the course of the next several days, pt began complaining of worsening L shoulder pain with restricted ROM.  She was give one dose of steroids but this only helped minimally.  Ortho was consulted and arthrocentesis performed; cell count was c/w infection.  Pt subsequently went to OR 11/13 for washout.  Was found to ave L subdeltoid abscess that tracked to joint.  +rotator cuff tear.     Notably, pt with worsening pain since Covid bivalent vaccine administered in L deltoid 10/26/22
AUG2021 13AUG2021 -1st day I had achiness like flu and step by step, I woke up with a headache, coughing, sinuses in my ears, no vomiting or anything. It was the congestion was worst. My ears was plugged so bad, like half on both ears. No fever for 2day, then 3rd day 99.5 and next day 100.2. On 16AUG2021 Covid test. 19 Aug2021 had monoclonal body infusion.
This spontaneous report was received from the registered nurse and refers to a patient of unknown age and gender. On 03-DEC-2014, the patient was given ROTATEQ lot# K005273, expiration date: 23-FEB-2016, that was involved in temperature excursion in 18-NOV-2014. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 69 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "pulmonary" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID-19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient received vaccine. Patient received other medication in 2weeks. Patient had no known allergies. Patient received Paxlovid as COVID 19 Treatment from unspecified date in Sep2022 to unspecified date Sep2022.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Information has been received from a certified medical assistant (C.M.A.) concerning a 79 year old female who on 30-OCT-2006 was vaccinated with Pneumovax 23 (lot # 651400/0618F) 0.5 ml subcutaneously.  On 31-OCT-2006, the patient experienced redness and raised area the size of silver dollar at the injection site.  The patient sought medical attention.  The outcome of the event was not reported.  Additional information has been received from an other unspecified.  No diagnostic tests were performed.  On an unspecified date, the patient recovered.  No further information is expected.
Pt.'s family member phoned clinic from cell phone in car to report pt - c/o lips swelling with numbness/tingling, approx 1 hour after vaccination. Advised to proceed directly to E.R.
A report has been received from a Health Professional concerning a 5 year old, Female patient. Patient relevant history, concurrent diseases and concomitant drugs were not reported. The patient received nasal FLUMIST Quadrivalent on 18-DEC-2014. It was reported that the patient experienced flu like symptoms which started on 22-DEC-2014. The outcome of the event of flu like symptoms was unknown. The report was considered to be non-serious.
high blood pressure; blockage / two cardiac stents placed; This is a spontaneous report from a non-contactable consumer (patient). This 57 years old male patient received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 02Feb2021 at 05:00 (at 57 years of age) for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient experienced high blood pressure on 11Feb2021. The event required ER visit on 11Feb2021, physician office visit and was reported as serious per hospitalization for 3 days and as life-threatening. Cardiac cath lab was performed on 12Feb2021 and blockage was found, resulting in two cardiac stents placed. Device date: 25May2021. High blood pressure resolved with sequel on an unspecified date in 2021. Blockage outcome was unknown. On 25Feb2021 at 05:30 the patient received the second vaccination. On 15Apr2021, the patient had another emergency trip to ER, another blockage in the left anterior descending artery. This blockage was only 40% blocked in Feb2021 and suddenly in Apr2021 became 99% blocked. Dr suspected a blook clot when symptoms of shortness of breath appeared suddenly. Since the vaccination, the patient had been tested for COVID-19 (on an unknown date in 2021, with unknown results).  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021601862 same patient, different vaccine dose/events
Tingling and slight swelling of lips started 1 hour after injection.  This the fifth day and still experiencing symptons,  started to take Benadryl for the past 5 days.  Diarrhea for 5 days and no appetite.  Take acid reducing meds.
Numbness / tingling in Lt arm / Lt. shoulder  area.                                                      3-27-21
Fever 24 hours after vaccine Local redness, tenderness, swelling 48 hours after vaccine, localized to injection site
Information has been received from a 62 year old female patient referring to herself. The patient's medical history included chickenpox and pneumonia. The patient was allergic to amoxicillin. On 04-NOV-2015 the patient was vaccinated with a dose of PNEUMOVAX 23 (lot# L033707 with expiration date of 18-MAY-2017, 1 shot, once, strength unknown, intramuscular) for prevention of pneumonia. Concomitant medication included ZYRTEC (genetic). The next day on 05-NOV-2015, after receiving the vaccine the patient did not feel good and felt "drained" with fevers and chills. The patient also stated that her arm ached and was hot, and covered with welts from shoulder to elbow and in between. The patient sought medical attention by speaking to physician's office. BENADRYL, ibuprofen and cortisone cream were given for the treatment. No lab diagnostics were performed. The patient was not recovered from the event. Additional information has been requested.
Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Slight headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Slight headache). On 09-Mar-2021, HEADACHE (Slight headache) had resolved.            No Concomitant medication was reported.  No Treatment medication was reported.   This case was linked to MOD-2021-232713 (Patient Link).
1-9-2020 4:30 pm: Nausea, dizzy, headache, face hot/extremities cold 1-10-2020 1 am Temp 100.7   Mom administered 50 mg Benadryl
started feeling or hearing popping sensation in the left shoulder and Severe pain in the shoulder and arm was reported as worsened.; Severe pain in the shoulder and arm; Severe pain in the shoulder and arm; tips of the fingers in the left hand were numb; started feeling or hearing popping sensation in the left shoulder; cannot use the arm to get dressed, shower, lift arm in certain angles, or push and pull; This is a spontaneous report from a contactable consumer. A 46-Year-old female consumer (patient) reported for herself that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EW0150 and expiry date Jul2021) via an unspecified route of administration on 17Apr2021 in left arm (at 46-year-old), as dose 1, single for COVID-19 immunization. Medical history included hypertension from an unknown date and unknown if ongoing and overweight from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously received DPT and experienced anaphylaxis. It was mentioned no investigation assessment was done. The prior vaccinations (within 4 weeks), event following prior vaccinations, family medical history and relevant tests were reported as none. On 17Apr2021 almost immediately after the vaccination the patient's tips of the fingers in the left hand were numb and started feeling or hearing popping sensation in the left shoulder. It went away within an hour, it felt weird. She recovered completely and treatment was reported as none, it resolved on its own. On 18Apr2021 the patient experienced severe pain in the shoulder and arm. On an unknown date in Apr2021 she could not use the arm to get dressed, shower, lift arm in certain angles, or push and pull. No treatment was received, the doctor recommended that she continued to move the arm somewhat so she would not get frozen shoulder. She got an x-ray that showed no fracture or dislocation.It was mentioned that started feeling or hearing popping sensation in the left shoulder and Severe pain in the shoulder and arm was reported as worsened (condition aggravated). The patient did not require emergency room visit, but she visited physician office. On an unknown date in 2021 tips of the fingers in the left hand were numb recovered. The other events had not recovered.
Period was 4 days early (Jan 14 instead of Jan 18) and lasted 9 days instead of 5 days. Bleeding was a lot heavier than normal. Ovulated 10 days later than normal in next cycle.   I had been keeping track because we were trying to get pregnant. My periods are always very regular. I became pregnant with EDD 10/31/21 and suffered miscarriage on 3/21/21. Genetic screening from fetal tissue showed digynic triploidy. I do not necessarily think vaccine caused miscarriage however I am just stating what happened with my cycle immediately prior to getting pregnant.
Patient's hemoglobin dropped from 8 to 6. She was hospitalized from 6/14 to 6/18. As of 6/21 she stated that her hemoglobin is continuing to drop. She received two transfusions in the hospital.  She is not necessarily claiming that the vaccine caused this, but we decided to file a VAERS report.
Pfizer (EM9810) Dose #1 on 5 Feb 2021 Pfizer (EN6202) Dose #2 on 26 Feb 2021 Pfizer (FF8839) Booster on 9 Dec 2021   Approximately 2.5 weeks after my second dose, I experienced a dull chest pain on the left (heart) side.  Along with this chest pain I experienced an intermittent shortness of breath and a light headed sensation.  My first thought was I had strained my chest while swimming, but after the condition didn?t improve I scheduled with a cardiologist for a check-up.  Dr. did not detect any condition to explain the symptoms.  My cholesterol was a little above normal so I started a statin. The duration of the chest pain was between mid-March and August and then no longer noticeable until the booster.    I received my booster last month (Dec) and 2 weeks later the same symptoms returned (chest pain, and intermittent shortness of breath and a light headed sensation).  I?ve contacted my cardiologist again to let them know.  The chest pain is a 3 out of 10.  The plan is if this level increases significantly I would go to the ER.    I have only experienced the specific symptoms described above these two times in my life so thought it worth reporting.  Please let me know if I need to share any additional information.
approx. 3:10 pm lightheaded, dizzy, flushed, sweaty, shaky, nauseous, headache 5/10 after interventions, feet elevated, ice pack, water, cracker, patient reported improving symptoms at 4;11pm BP 3:20 122/88 HR 87 pulse ox 97 on room air recheck bp 116/74 at 3:45pm HR 82 pulse ox 98 on room air Patient departed vaccine clinic at 3:15pm a friend was called to drive her home. she stood and ambulated with steady gait unassisted patient alert and oriented to name, dob, place, time at all times
Within 4 hours of Prevnar, pt awoke with a temperature of 103.7F and was given Tylenol and Motrin. Eight hours, post vax, he had generalized tonic-clonic seizure associated with alteration in level of consciousness. Seizure lasted 1-2 minutes and was not with respiratory distress. Pt went to sleep after seizure and awoke without fever. The next morning he was back to baseline. (Pt has abnormal neuro status even at baseline-mainly abnormal behavior and development and is being referred to a neurologist). Also mom notes there was redness and soreness at the injection site for 2 days.
I experienced a herpes (hsv 2) outbreak about 60 hours after receiving my second vaccination